López-Pérez, Ana
Norlin, Stefan
Steneberg, Pär
Remeseiro, Silvia
Edlund, Helena
Hörnblad, Andreas
Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse (KAW 2015.0278)
The Strategic Research Program in Diabetes at Umeå University
Kempestiftelserna, Sweden (SMK-1863)
Umea University
Article History
Received: 22 September 2021
Accepted: 6 December 2021
First Online: 23 December 2021
Competing interests
: HE is a cofounder, shareholder, and consultant of the unlisted biotech company Betagenon AB. All other authors declare no competing interests.